FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W92425446> ?p ?o ?g. }

• W92425446 endingPage "469" @default.
• W92425446 startingPage "461" @default.
• W92425446 abstract "In the course of allogeneic bone marrow transplantation (BMT), avoiding graft-versus-host disease (GVHD) while retaining the antileukemic effects of the T cells remains a major challenge. T-cell depletion (TCD) reduces the incidence of GVHD but increases the relapse rate after allogeneic BMT. We attempted to develop a regimen that would retain or increase the graft-versus-leukemia effect induced by donor T cells while preventing GVHD. Immunosuppressed mice were given immunocompetent donor cells, i.e., fresh lymphocytes or lymphokine-activated killer (LAK) cells differing from the host in major (MHC) or minor (MiHC) histocompatibility antigens. Engraftment of donor cells was documented by polymerase chain reaction analysis. Administration of MHC- and MiHC-incompatible allogeneic LAK cells, especially in conjunction with recombinant interleukin-2 (rIL-2), increased disease manifestations and mortality associated with GVHD. On the other hand, irradiated LAK cells or TCD-LAK cells prevented GVHD in both mice models studied. Phenotypic analysis of LAK cells demonstrated that CD8+-equivalent (Lyt-2) T cells are of significance in aggravation of GVHD. The in vitro cytotoxic capacity of LAK cells against MHC-nonrestricted target cells was not reduced by either irradiation or TCD. These results provide the background for designing improved protocols for immunotherapy of residual disease after BMT. In addition, the data imply that antitumor effects may be retained by irradiated rIL-2–activated allogeneic cells without causing GVHD. Whereas unmodified allogeneic LAK cells can induce more effective graft-versus-leukemia effects at the cost of GVHD, irradiated allogeneic donor LAK cells might play some role in eradication of minimal residual disease following autologous or allogeneic BMT without causing GVHD." @default.
• W92425446 created "2016-06-24" @default.
• W92425446 creator A5018290889 @default.
• W92425446 creator A5059915616 @default.
• W92425446 creator A5082078271 @default.
• W92425446 creator A5085118623 @default.
• W92425446 date "1999-03-01" @default.
• W92425446 modified "2023-10-15" @default.
• W92425446 title "Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease" @default.
• W92425446 cites W1274344746 @default.
• W92425446 cites W1489678151 @default.
• W92425446 cites W1894913781 @default.
• W92425446 cites W1981715129 @default.
• W92425446 cites W1982980552 @default.
• W92425446 cites W2001499325 @default.
• W92425446 cites W2009593365 @default.
• W92425446 cites W2014712274 @default.
• W92425446 cites W2018060807 @default.
• W92425446 cites W2022584463 @default.
• W92425446 cites W2027284207 @default.
• W92425446 cites W2044832723 @default.
• W92425446 cites W2074222658 @default.
• W92425446 cites W2076636340 @default.
• W92425446 cites W2149737277 @default.
• W92425446 cites W2297816245 @default.
• W92425446 cites W2325605534 @default.
• W92425446 cites W309638826 @default.
• W92425446 cites W44995847 @default.
• W92425446 cites W45841919 @default.
• W92425446 doi "https://doi.org/10.1016/s0301-472x(98)00026-5" @default.
• W92425446 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10089908" @default.
• W92425446 hasPublicationYear "1999" @default.
• W92425446 type Work @default.
• W92425446 sameAs 92425446 @default.
• W92425446 citedByCount "13" @default.
• W92425446 countsByYear W924254462012 @default.
• W92425446 countsByYear W924254462014 @default.
• W92425446 crossrefType "journal-article" @default.
• W92425446 hasAuthorship W92425446A5018290889 @default.
• W92425446 hasAuthorship W92425446A5059915616 @default.
• W92425446 hasAuthorship W92425446A5082078271 @default.
• W92425446 hasAuthorship W92425446A5085118623 @default.
• W92425446 hasBestOaLocation W924254461 @default.
• W92425446 hasConcept C126322002 @default.
• W92425446 hasConcept C129374314 @default.
• W92425446 hasConcept C147483822 @default.
• W92425446 hasConcept C154317977 @default.
• W92425446 hasConcept C167672396 @default.
• W92425446 hasConcept C202751555 @default.
• W92425446 hasConcept C203014093 @default.
• W92425446 hasConcept C207936829 @default.
• W92425446 hasConcept C2777701055 @default.
• W92425446 hasConcept C2778461978 @default.
• W92425446 hasConcept C2779823535 @default.
• W92425446 hasConcept C2779972918 @default.
• W92425446 hasConcept C2780007613 @default.
• W92425446 hasConcept C28651165 @default.
• W92425446 hasConcept C2911091166 @default.
• W92425446 hasConcept C48556533 @default.
• W92425446 hasConcept C502942594 @default.
• W92425446 hasConcept C55493867 @default.
• W92425446 hasConcept C71924100 @default.
• W92425446 hasConcept C86803240 @default.
• W92425446 hasConcept C8891405 @default.
• W92425446 hasConceptScore W92425446C126322002 @default.
• W92425446 hasConceptScore W92425446C129374314 @default.
• W92425446 hasConceptScore W92425446C147483822 @default.
• W92425446 hasConceptScore W92425446C154317977 @default.
• W92425446 hasConceptScore W92425446C167672396 @default.
• W92425446 hasConceptScore W92425446C202751555 @default.
• W92425446 hasConceptScore W92425446C203014093 @default.
• W92425446 hasConceptScore W92425446C207936829 @default.
• W92425446 hasConceptScore W92425446C2777701055 @default.
• W92425446 hasConceptScore W92425446C2778461978 @default.
• W92425446 hasConceptScore W92425446C2779823535 @default.
• W92425446 hasConceptScore W92425446C2779972918 @default.
• W92425446 hasConceptScore W92425446C2780007613 @default.
• W92425446 hasConceptScore W92425446C28651165 @default.
• W92425446 hasConceptScore W92425446C2911091166 @default.
• W92425446 hasConceptScore W92425446C48556533 @default.
• W92425446 hasConceptScore W92425446C502942594 @default.
• W92425446 hasConceptScore W92425446C55493867 @default.
• W92425446 hasConceptScore W92425446C71924100 @default.
• W92425446 hasConceptScore W92425446C86803240 @default.
• W92425446 hasConceptScore W92425446C8891405 @default.
• W92425446 hasIssue "3" @default.
• W92425446 hasLocation W924254461 @default.
• W92425446 hasLocation W924254462 @default.
• W92425446 hasOpenAccess W92425446 @default.
• W92425446 hasPrimaryLocation W924254461 @default.
• W92425446 hasRelatedWork W1549955232 @default.
• W92425446 hasRelatedWork W183718965 @default.
• W92425446 hasRelatedWork W1993381802 @default.
• W92425446 hasRelatedWork W1996701413 @default.
• W92425446 hasRelatedWork W2062293155 @default.
• W92425446 hasRelatedWork W2068154221 @default.
• W92425446 hasRelatedWork W2103608079 @default.
• W92425446 hasRelatedWork W2370661437 @default.

• next